BioNexus Gene Lab Long Term Debt

BioNexus Gene Lab (BGLC) currently reports a long-term debt of $140K as of June 2026. That compares with $140K in the prior-year period — down 4.5% year over year. Use the charts on this page to explore BioNexus Gene Lab's long-term debt history and peer comparisons.

BioNexus Gene Lab's long-term debt decreased from $140K to $140K — a 4.5% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

BioNexus Gene Lab reported $140K in long-term debt as of June 2026. That compares with $140K in the prior-year period — down 4.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $140K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for BioNexus Gene Lab, and consider following BGLC for alerts when major investors trade the stock.